WO2002011549A3 - Treatment of mycobacterial infection - Google Patents
Treatment of mycobacterial infection Download PDFInfo
- Publication number
- WO2002011549A3 WO2002011549A3 PCT/GB2001/003625 GB0103625W WO0211549A3 WO 2002011549 A3 WO2002011549 A3 WO 2002011549A3 GB 0103625 W GB0103625 W GB 0103625W WO 0211549 A3 WO0211549 A3 WO 0211549A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- methods
- mycobacterial infection
- humans
- animals
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C3/00—Preservation of milk or milk preparations
- A23C3/08—Preservation of milk or milk preparations by addition of preservatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K30/00—Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs
- A23K30/10—Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs of green fodder
- A23K30/15—Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs of green fodder using chemicals or microorganisms for ensilaging
- A23K30/18—Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs of green fodder using chemicals or microorganisms for ensilaging using microorganisms or enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10311—Siphoviridae
- C12N2795/10332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001282277A AU2001282277A1 (en) | 2000-08-10 | 2001-08-10 | Treatment of mycobacterial infection |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0019721.0A GB0019721D0 (en) | 2000-08-10 | 2000-08-10 | Novel method |
GB0019721.0 | 2000-08-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002011549A2 WO2002011549A2 (en) | 2002-02-14 |
WO2002011549A3 true WO2002011549A3 (en) | 2002-08-22 |
Family
ID=9897393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2001/003625 WO2002011549A2 (en) | 2000-08-10 | 2001-08-10 | Treatment of mycobacterial infection |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001282277A1 (en) |
GB (1) | GB0019721D0 (en) |
WO (1) | WO2002011549A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2799063A1 (en) * | 2013-04-30 | 2014-11-05 | Ferring B.V. | Bacteriophage therapy |
CN108126190B (en) * | 2017-11-02 | 2021-01-26 | 重庆医科大学附属第一医院 | Preparation and application of mycobacterium phage lyase Lysin-Guo1 |
WO2020061002A1 (en) * | 2018-09-18 | 2020-03-26 | Map/Path Llc | Methods and composition for controlling map infection and contamination |
CN115902217B (en) * | 2023-03-08 | 2023-06-16 | 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) | Indirect ELISA (enzyme-Linked immuno sorbent assay) detection kit for bovine paratuberculosis and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997022713A1 (en) * | 1995-12-15 | 1997-06-26 | Biotec Laboratories Limited | Method to detect bacteria |
WO1999057304A1 (en) * | 1998-05-02 | 1999-11-11 | Scottish Crop Research Institute | Bacteriophage assay |
US6254866B1 (en) * | 1997-10-31 | 2001-07-03 | New Horizons Diagnostics Corporation | Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract |
-
2000
- 2000-08-10 GB GBGB0019721.0A patent/GB0019721D0/en not_active Ceased
-
2001
- 2001-08-10 WO PCT/GB2001/003625 patent/WO2002011549A2/en active Application Filing
- 2001-08-10 AU AU2001282277A patent/AU2001282277A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997022713A1 (en) * | 1995-12-15 | 1997-06-26 | Biotec Laboratories Limited | Method to detect bacteria |
US6254866B1 (en) * | 1997-10-31 | 2001-07-03 | New Horizons Diagnostics Corporation | Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract |
WO1999057304A1 (en) * | 1998-05-02 | 1999-11-11 | Scottish Crop Research Institute | Bacteriophage assay |
Also Published As
Publication number | Publication date |
---|---|
WO2002011549A2 (en) | 2002-02-14 |
AU2001282277A1 (en) | 2002-02-18 |
GB0019721D0 (en) | 2000-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1212422T3 (en) | Human CTLA-4 antibodies and their uses | |
WO1999052515A3 (en) | Use of organophosphoric compounds for the therapeutic and preventative treatment of infections | |
NO20041882L (en) | Methods for the treatment of ocular neovascular diseases. | |
DE60137631D1 (en) | IREOVIRUS ANTIBODIES FOR THE TREATMENT OF RAS-MEDIATED, PROLIFERATIVE DISEASES | |
BR0309095A (en) | Use of osteoprotegerin for the treatment and / or prevention of fibrotic disease. | |
BRPI0407662A (en) | 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases | |
IL169701A0 (en) | The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl | |
WO2003099217A3 (en) | Methods of treating bacterial infections and diseases associated therewith | |
DE69835536D1 (en) | COMPOSITIONS FOR THE TREATMENT OF STAPHYLOCOCCUS AUREUS INFECTIONS | |
DE60236318D1 (en) | PREPARATIONS OF GRAMPOSITIVE BACTERIA FOR THE TREATMENT OF DISEASES WITH IMMUNE RADIATION | |
DE60016047D1 (en) | DIHYDROBENZOPYRANE, DIHYDROBENZOTHIOPYRANE AND TETRAHYDROCHINOLINE FOR THE TREATMENT OF COX-2-DEPENDENT DISEASES | |
AU2180501A (en) | Novel DNA polymerase inhibitors, mikanolide and dihydromikanolide | |
WO2002011549A3 (en) | Treatment of mycobacterial infection | |
WO2002020619A3 (en) | HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) | |
BR0013800B1 (en) | insecticidal compositions for the control of beetles and processes for the control of beetles. | |
WO2002032445A3 (en) | Inhibition of the interaction between oxidized proteins and cd36 or the active mechanism thereof | |
WO2001044235A3 (en) | Agents and methods for the treatment of proliferative diseases | |
AU2003237088A1 (en) | Compounds, compositions and methods for treating or preventing viral infections and associated diseases | |
WO2003024996A3 (en) | Antibacterial macrocycles | |
DE60124093D1 (en) | S-methyl-dihydro-ziprasidone for the treatment of eye diseases. | |
WO2004073604A3 (en) | Dna vaccines that express an adp-ribosyltransferase toxin devoid of adp-ribosyltransferase activity | |
DE69935662D1 (en) | MEANS FOR THE PREVENTION / TREATMENT OF INFLAMMATORY ENDURANCE | |
WO2001072334A3 (en) | Methods for treating disease with antibodies to cxcr3 | |
ATE364625T1 (en) | PROTEINS FROM YABA MONKEY TUMOR VIRUS WITH MODULATORY ACTIVITY | |
WO2000041526A3 (en) | Use of s-triazines for treating apicomplexan parasitic infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |